🇮🇳IN
Sign In
RE

REMUS

NSE

REMUS PHARMACEUTICALS L

₹880.60

-20.60(-2.29%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

REMUS valuation summary

REMUS PHARMACEUTICALS L trades at 44.0 times trailing earnings. Return on equity is 8.5% and return on capital employed is 11.5%. The dividend yield is 0.11%.

P/E44.0
ROE8.5%
ROCE11.5%
Dividend yield0.11%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer